TLR7 and COVID-19: On the other hand, a study from a cohort comprising 5085 participants with severe COVID-19 and 571,737 controls that combined whole-exome and whole-genome sequencing and a rare variant burden test meta-analysis observed that carrying a rare deleterious variant in TLR7 was associated with a 5.3-fold increase in severe disease.